Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial. (28th May 2021)
- Record Type:
- Journal Article
- Title:
- Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial. (28th May 2021)
- Main Title:
- Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial
- Authors:
- Yaskolka Meir, Anat
Keller, Maria
Müller, Luise
Bernhart, Stephan H.
Tsaban, Gal
Zelicha, Hila
Rinott, Ehud
Kaplan, Alon
Gepner, Yftach
Shelef, Ilan
Schwarzfuchs, Dan
Ceglarek, Uta
Stadler, Peter
Blüher, Matthias
Stumvoll, Michael
Kovacs, Peter
Shai, Iris - Abstract:
- Abstract: Background and Aims: In the CENTRAL trial context, we found diverse liver fat dynamics in response to different dietary interventions. Epigenetic mechanisms may contribute to the intraindividual variation. Moreover, genetic factors are involved in developing nonalcoholic fatty‐liver disease (NAFLD), a disease reflected by an increase in intrahepatic fat (IHF). In this exploratory analysis, we primarily aimed to examine the effect of lifestyle interventions on DNA‐methylation of NAFLD related genes associated with IHF. Methods: For 120 participants from the CENTRAL trial, an 18‐month regimen of either low‐fat (LF) or Mediterranean‐low carbohydrate (MED/LC) diets, with or without physical activity (PA+/PA−), was instructed. Magnetic resonance imaging was used to measure IHF%, which was analysed for association with CpG specific DNA‐methylation levels of 41 selected candidate genes. Single‐nucleotide polymorphisms known to be associated with NAFLD within the studied genes were genotyped by TaqMan assays. Results: At baseline, participants (92% men; body mass index = 30.2 kg/m 2 ) had mean IHF of 10.7% (59% NAFLD). Baseline‐IHF% was inversely correlated with DNA‐methylation at individual CpGs within AC074286.1, CRACR2A, A2MP1, FARP1 ( P < .05 for all multivariate models). FARP1 rs9584805 showed association with IHF, with the prevalence of NAFLD and baseline methylation level of the CpG site (cg00071727) associated with IHF%. Following 18‐month lifestyle intervention,Abstract: Background and Aims: In the CENTRAL trial context, we found diverse liver fat dynamics in response to different dietary interventions. Epigenetic mechanisms may contribute to the intraindividual variation. Moreover, genetic factors are involved in developing nonalcoholic fatty‐liver disease (NAFLD), a disease reflected by an increase in intrahepatic fat (IHF). In this exploratory analysis, we primarily aimed to examine the effect of lifestyle interventions on DNA‐methylation of NAFLD related genes associated with IHF. Methods: For 120 participants from the CENTRAL trial, an 18‐month regimen of either low‐fat (LF) or Mediterranean‐low carbohydrate (MED/LC) diets, with or without physical activity (PA+/PA−), was instructed. Magnetic resonance imaging was used to measure IHF%, which was analysed for association with CpG specific DNA‐methylation levels of 41 selected candidate genes. Single‐nucleotide polymorphisms known to be associated with NAFLD within the studied genes were genotyped by TaqMan assays. Results: At baseline, participants (92% men; body mass index = 30.2 kg/m 2 ) had mean IHF of 10.7% (59% NAFLD). Baseline‐IHF% was inversely correlated with DNA‐methylation at individual CpGs within AC074286.1, CRACR2A, A2MP1, FARP1 ( P < .05 for all multivariate models). FARP1 rs9584805 showed association with IHF, with the prevalence of NAFLD and baseline methylation level of the CpG site (cg00071727) associated with IHF%. Following 18‐month lifestyle intervention, differential DNA‐methylation patterns were observed between diets at cg14335324 annotated to A2MP1 ( P = .04, LF vs. MED/LC), and differential DNA‐methylation between PA groups within AC074286.1, CRACR2A, and FARP1 CpGs ( P < .05 for all, PA−vs. PA+). Conclusions: This study suggests epigenetic markers for IHF and potential epigenetic remodeling after long‐term lifestyle interventions. … (more)
- Is Part Of:
- Liver international. Volume 41:Number 9(2021)
- Journal:
- Liver international
- Issue:
- Volume 41:Number 9(2021)
- Issue Display:
- Volume 41, Issue 9 (2021)
- Year:
- 2021
- Volume:
- 41
- Issue:
- 9
- Issue Sort Value:
- 2021-0041-0009-0000
- Page Start:
- 2101
- Page End:
- 2111
- Publication Date:
- 2021-05-28
- Subjects:
- Diet -- DNA‐methylation -- genetic variation -- nonalcoholic fatty liver disease -- physical activity
Liver -- Periodicals
Liver -- Diseases -- Periodicals
616.362 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1478-3231 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/liv.14916 ↗
- Languages:
- English
- ISSNs:
- 1478-3223
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5280.514000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23920.xml